Embracing Heterogeneity in The Multicenter Stroke Preclinical Assessment Network (SPAN) Trial is a research paper published in Stroke (2023). On theSindex it has a DataRank of 0. It has been cited 34 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NINDS NIH HHS
Grant: U01 NS113443
NINDS NIH HHS
Grant: U01 NS130590
NCATS NIH HHS
Grant: UL1 TR001863
NINDS NIH HHS
Grant: U01 NS113451
NINDS NIH HHS
Grant: U24 NS113452
NCATS NIH HHS
Grant: UL1 TR002541
NINDS NIH HHS
Grant: U01 NS130588
NIBIB NIH HHS
Grant: P41 EB015922
NINDS NIH HHS
Grant: U01 NS113445
National Institutes of Health
Grant: 1U01NS113451-01
Stroke Preclinical Assessment Network (SPAN) – Tacilizumab for treatment of acute ischemic stroke
National Institutes of Health
Grant: 5UL1TR002541-04
The Harvard Clinical and Translational Science Center
National Institutes of Health
Grant: 7P41EB015922-17
Laboratory of Neuro Imaging Resource (LONIR)
National Institutes of Health
Grant: 5U01NS113445-02
Yale site for Stroke Preclinical Assessment Network (SPAN) for Acute Neuroprotection
National Institutes of Health
Grant: 5U24NS113452-02
The NIH SPAN Coordinating Center
National Institutes of Health
Grant: 5U01NS113443-03
Multicenter preclinical trial of rho-kinase inhibitor fasudil in acute focal cerebral ischemia and reperfusion
FWCI
6.23
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals